In Brief: Laboratory practices
Laboratory practices: Meeting to be held Nov. 20 to discuss issues of mutual concern to FDA and industry regarding pharmaceutical laboratory practices and procedures. Future meetings on the subject will address acceptable "best practices," research/quality assurance, acceptable uses of technology, changes in technology and pharmaceutical science-data integrity. Topics and comments may be submitted by Nov. 8. The meeting will be held in conference room E of FDA's Parklawn building starting at 8:30 a.m...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth